Poster # 2438 Moderate Hypofractionation And Simultaneous Integrated Boost With Volumetric Modulated Arc Therapy By Rapidarc For Prostate Cancer: Report Of Feasibility And Acute Toxicity.

Presenter: Filippo Alongi, MD

About the Presenter:
FILIPPO ALONGI, MD. Since 2012: Senior Consultant at Humanitas Cancer Center in Milan, Italy. The current field of research is hypofractionation, SBRT in oligometastases, the use of FFF mode in VMAT delivery. 2010: Assistant at Department of Radiotherapy and Radiosurgery of Humanitas, in Milan, Italy, focusing his activity on cancers of the head and neck, breast and prostate. He worked with the first TrueBeam in Italy. 2008-2010: Researcher at National Research Council(CNR), Italy. Main field of research: innovative technologies in Oncology(Tomotherapy, IMRT, MrgFUS,IORT). 2006-2010: Radiation Oncologist, assistant, at San Raffaele Institute, Milan, Italy, when he worked with the first Tomotherapy in Italy. Since 2011: Council AIRO (Italian Association of Radiation Oncology) "Young group". He is author/coauthor of more than 100 scientific abstracts/papers presented at national and international conferences, where he participated as a speaker, teacher and moderator. He is also the author and / or co-author of 3 book chapthers and more than 45 publications(available on pubmed;Scopus) in peer reviewed journals with impact factor, regarding radiotherapy and oncology.



 View the poster



E-mail a friend about this poster:
Enter email address: